{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:26:35Z","timestamp":1774617995761,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["TW-00069"],"award-info":[{"award-number":["TW-00069"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1916-1","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T14:38:05Z","timestamp":1476715085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells\/mm3"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-5966","authenticated-orcid":false,"given":"Simon","family":"Mutembo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane N.","family":"Mutanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebby","family":"Musokotwane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutangu","family":"Alisheke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"1916_CR1","unstructured":"World Health Organization. Antiretroviral Therapy for HIV infection in Adults and Adolescents: Recommendations for a public health approach. 2010. \u00a0Geneva: WHO Press, World Health Organization."},{"issue":"7","key":"1916_CR2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/infdis\/jiq141","volume":"203","author":"CL Lancioni","year":"2011","unstructured":"Lancioni CL, et al. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells\/mm3. J Infect Dis. 2011;203(7):992\u20131001.","journal-title":"J Infect Dis"},{"issue":"4","key":"1916_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1056\/NEJM199201233260404","volume":"326","author":"CL Daley","year":"1992","unstructured":"Daley CL, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992;326(4):231\u20135.","journal-title":"N Engl J Med"},{"issue":"1","key":"1916_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/375220","volume":"37","author":"EL Korenromp","year":"2003","unstructured":"Korenromp EL, et al. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Inf Dis. 2003;37(1):101\u201312.","journal-title":"Clin Inf Dis"},{"issue":"18","key":"1916_CR5","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","volume":"360","author":"M Kitahata","year":"2009","unstructured":"Kitahata M, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815\u201326.","journal-title":"N Engl J Med"},{"issue":"9672","key":"1916_CR6","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","volume":"373","author":"JAC Sterne","year":"2009","unstructured":"Sterne JAC, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352\u201363.","journal-title":"Lancet"},{"issue":"16","key":"1916_CR7","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","volume":"365","author":"S Abdool Karim","year":"2011","unstructured":"Abdool Karim S, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365(16):1492\u2013501.","journal-title":"N Engl J Med"},{"issue":"8","key":"1916_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa0905848","volume":"362","author":"S Abdool Karim","year":"2010","unstructured":"Abdool Karim S, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362(8):697\u2013706.","journal-title":"N Engl J Med"},{"issue":"16","key":"1916_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","volume":"365","author":"F-X Blanc","year":"2011","unstructured":"Blanc F-X, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365(16):1471\u201381.","journal-title":"N Engl J Med"},{"issue":"16","key":"1916_CR10","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"D Havlir","year":"2011","unstructured":"Havlir D, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365(16):1482\u201391.","journal-title":"N Engl J Med"},{"issue":"7","key":"1916_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S1473-3099(14)70733-9","volume":"14","author":"SG Mfinanga","year":"2014","unstructured":"Mfinanga SG, et al. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis. 2014;14(7):563\u201371.","journal-title":"Lancet Infect Dis"},{"key":"1916_CR12","unstructured":"World Health Organization. Rapid Advice: Antiretroviral therapy for HIV infection in adults and adolescents. 2009. Available from: http:\/\/www.who.int\/hiv\/pub\/arv\/rapid_advice_art.pdf . Accessed 13 July 2016."},{"issue":"7","key":"1916_CR13","doi-asserted-by":"publisher","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","volume":"9","author":"AB Suthar","year":"2012","unstructured":"Suthar AB, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001270.","journal-title":"PLoS Med"},{"issue":"5","key":"1916_CR14","doi-asserted-by":"publisher","first-page":"e1001029","DOI":"10.1371\/journal.pmed.1001029","volume":"8","author":"MF Franke","year":"2011","unstructured":"Franke MF, et al. Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study. PLoS Med. 2011;8(5):e1001029.","journal-title":"PLoS Med"},{"issue":"6","key":"1916_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/00002030-200004140-00020","volume":"14","author":"A Munoz","year":"2000","unstructured":"Munoz A, Gange SJ, Jacobson LP. Distinguishing efficacy, individual effectiveness and population effectiveness of therapies. AIDS. 2000;14(6):754\u20136.","journal-title":"AIDS"},{"issue":"6","key":"1916_CR16","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1365-3156.2012.02981.x","volume":"17","author":"N Kapata","year":"2012","unstructured":"Kapata N, et al. Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year review. Trop Med Int Health. 2012;17(6):760\u20136.","journal-title":"Trop Med Int Health"},{"issue":"2","key":"1916_CR17","first-page":"82","volume":"16","author":"J Gallant","year":"2008","unstructured":"Gallant J. When to start antiretroviral therapy: a swinging pendulum? Top HIV Med. 2008;16(2):82\u20138.","journal-title":"Top HIV Med"},{"key":"1916_CR18","doi-asserted-by":"crossref","unstructured":"Kassambara A, Kosinski M. survminer: DrawingSurvival Curves using 'ggplot2'. 2016.","DOI":"10.32614\/CRAN.package.survminer"},{"key":"1916_CR19","unstructured":"R core team, R: A Language and Environment for Statistical Computing. 2016."},{"issue":"9163","key":"1916_CR20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/S0140-6736(99)03465-0","volume":"353","author":"SZ Wiktor","year":"1999","unstructured":"Wiktor SZ, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d\u2019Ivoire: a randomised controlled trial. Lancet. 1999;353(9163):1469\u201375.","journal-title":"Lancet"},{"issue":"6","key":"1916_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/infdis\/jir503","volume":"204","author":"MW Nanteza","year":"2011","unstructured":"Nanteza MW, et al. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4+ T-Cell Counts of \u2265350 cells\/\u03bcL. J Infect Dis. 2011;204(6):884\u201392.","journal-title":"J Infect Dis"},{"issue":"9443","key":"1916_CR22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","volume":"364","author":"J Mermin","year":"2004","unstructured":"Mermin J, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet. 2004;364(9443):1428\u201334.","journal-title":"Lancet"},{"issue":"4","key":"1916_CR23","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2352-3018(15)00005-3","volume":"2","author":"AB Suthar","year":"2015","unstructured":"Suthar AB, et al. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis. Lancet HIV. 2015;2(4):e137\u201350.","journal-title":"Lancet HIV"},{"issue":"10","key":"1916_CR24","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/QAD.0b013e32833a2a4a","volume":"24","author":"CF Hanrahan","year":"2010","unstructured":"Hanrahan CF, et al. Body mass index and risk of tuberculosis and death. AIDS. 2010;24(10):1501.","journal-title":"AIDS"},{"issue":"1","key":"1916_CR25","doi-asserted-by":"publisher","first-page":"e2300","DOI":"10.1097\/MD.0000000000002300","volume":"95","author":"Y-F Yen","year":"2016","unstructured":"Yen Y-F, et al. Association of body mass index with tuberculosis mortality: a population-based follow-up study. Medicine. 2016;95(1):e2300.","journal-title":"Medicine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1916-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:10:20Z","timestamp":1718842220000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1916-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1916-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,17]]},"assertion":[{"value":"10 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"572"}}